Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2011
07/07/2011WO2011080303A1 Generation of pancreatic hormone-expressing cells from human fibroblast-like limbal stem cells
07/07/2011WO2011080261A1 Method for improved cardiomyogenic differentiation of pluripotent cells
07/07/2011WO2011057144A3 Methods for modulating lif activity, treating immune disorders and diseases, and stimulatings immune responses
07/07/2011WO2011050985A8 Clonal expansion of b cells
07/07/2011WO2011023843A3 Production of artificial tissues by means of tissue engineering using agarose-fibrin biomaterials
07/07/2011WO2010147803A3 Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes
07/07/2011WO2009046346A3 Stem cell therapy for weight loss
07/07/2011US20110167522 Cyclin d polynucleotides, polypeptides and uses thereof
07/07/2011US20110167521 Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis
07/07/2011US20110167519 Heat stable variants of plant adenosine diphosphate glucose pyrophosphorylase small subunit
07/07/2011US20110167518 Zea mays sark promoter and uses thereof
07/07/2011US20110167517 Identification of diurnal rhythms in photosynthetic and non-photsynthetic tissues from zea mays and use in improving crop plants
07/07/2011US20110167516 Methods and compositions for the introduction and regulated expression of genes in plants
07/07/2011US20110167514 Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics
07/07/2011US20110167512 Hybrid artichoke variety nun 4006 ar
07/07/2011US20110167509 Cytoplasmic Male Sterile Leek Plants, Methods for the Preparation and Use Thereof, and a Cytoplasmic Male Sterile Garlic Plant
07/07/2011US20110167506 Method for evaluation of developmental toxicity
07/07/2011US20110167505 GFATS As Modifiers of the AXIN Pathway and Methods of Use
07/07/2011US20110166337 Maize Promoter P67 and Methods of Use
07/07/2011US20110166216 Compositions and Methods for Inhibiting Growth and Metastasis of Melanoma
07/07/2011US20110166212 Gene expression and pain
07/07/2011US20110166210 Improved expression of il-12 family heterodimers
07/07/2011US20110166205 Substituted alpha-l-bicyclic nucleosides
07/07/2011US20110166201 Mirnas as therapeutic targets in cancer
07/07/2011US20110166200 Methods of using mir210 as a biomarker for hypoxia and as a therapeutic agent for treating cancer
07/07/2011US20110166197 Antisense Modulation Of Amyloid Beta Protein Expression
07/07/2011US20110166195 Method for the formation of megamitochondria
07/07/2011US20110166191 3-(2-amino-ethyl)-5-(3-cyclohexyl-propylidene)-thiazolidine-2,4-dione and its derivatives as multiple signaling pathway inhibitors and for the treatment of cancer
07/07/2011US20110166178 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase
07/07/2011US20110166176 Compounds and compositions as modulators of gpr119 activity
07/07/2011US20110166145 Stabilization of hypoxia inducible factor (HIF) alpha
07/07/2011US20110166130 Novel potassium channel blockers and uses thereof
07/07/2011US20110166103 Boron-containing small molecules
07/07/2011US20110166075 Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment
07/07/2011US20110166058 Organic compositions to treat hsf1-related diseases
07/07/2011US20110166042 Methods for Producing Inducible and/or Repressible Expression Active Linear RNA Interference Cassettes and Inducible and/or Repressible Expression Active Linear Gene Cassettes and Their Uses
07/07/2011US20110165701 Monoclonal antibody and immunoassay using the same
07/07/2011US20110165682 Human Trophoblast Stem Cells and Use Thereof
07/07/2011US20110165679 Methods and compositions for targeted polynucleotide modification
07/07/2011US20110165678 New Tomato Ethylene Response Factors and Uses Thereof
07/07/2011US20110165677 Method for reducing deposits during the cultivation of organisms
07/07/2011US20110165676 Method for decellularization
07/07/2011US20110165675 Capping bioprosthetic tissue to reduce calcification
07/07/2011US20110165674 NK-1 Receptor Mediated Delivery of Agents to Cells
07/07/2011US20110165673 Methods of culturing bacterial species of the anaplasmataceae family
07/07/2011US20110165672 Buffy coat separator float system and method
07/07/2011US20110165671 Process for providing an assembly of cell microcarriers
07/07/2011US20110165670 Ketoreductases and Uses Thereof
07/07/2011US20110165653 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
07/07/2011US20110165651 High fidelity reverse transcriptases and the uses thereof
07/07/2011US20110165649 Methods and compositions to improve the health of plants, animals and microbes by manipulating protein entry into symbionts and their hosts
07/07/2011US20110165635 Methods and materials for processing a feedstock
07/07/2011US20110165629 Recombinase-Based Methods for Producing Expression Vectors and Compositions for Use in Practicing the Same
07/07/2011US20110165623 Compositions and Methods for the High Efficiency Expression of the Transforming Growth Factor-Beta Supergene Family
07/07/2011US20110165622 Humanized anti-factor d antibodies and uses thereof
07/07/2011US20110165621 Humanized antibodies
07/07/2011US20110165620 Method for the production of proteins or protein fragments
07/07/2011US20110165610 Compositions, systems, and methods for preservation and/or stabilization of a cell and/or macromolecule
07/07/2011US20110165609 Device, a system and a method for monitoring and/or cultivation of microscopic objects
07/07/2011US20110165602 Emission ratiometric indicators of phosphoinositides
07/07/2011US20110165601 Assay system
07/07/2011US20110165584 Variable Lymphocyte Receptors, Related Polypeptides and Nucleic Acids and Uses Thereof
07/07/2011US20110165581 Methods for screening for compounds for treating cancer
07/07/2011US20110165580 Response Element Regions
07/07/2011US20110165570 Method of effecting de-differentiation of a cell
07/07/2011US20110165553 Vitrified composition which preserves biological materials
07/07/2011US20110165306 Proline-specific protease from pencillium chrysogenum
07/07/2011US20110165194 HBV Vaccine and a Process of Preparing the Same
07/07/2011US20110165184 Cdh3 peptide and medicinal agent comprising the same
07/07/2011US20110165170 Osteopontin antibodies
07/07/2011US20110165169 Complement inhibitors and uses thereof
07/07/2011US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
07/07/2011US20110165165 Mammalian genes; related reagents and methods
07/07/2011US20110165161 Anti-epcam antibodies that induce apoptosis of cancer cells and methods using same
07/07/2011US20110165160 Neutrokine-alpha and neutrokine-alpha splice variant
07/07/2011US20110165156 Antibodies against human csf-1r and uses thereof
07/07/2011US20110165154 Compositions and methods using anti-cs1 antibodies to treat multiple myeloma
07/07/2011US20110165153 Anti cd37 antibodies
07/07/2011US20110165149 Targeting abcb5 for cancer therapy
07/07/2011US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
07/07/2011US20110165147 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor
07/07/2011US20110165143 Modulation of caspases and therapeutical applications
07/07/2011US20110165141 Compositions for treating bacterial infections
07/07/2011US20110165133 Method of de-differentiating and re-differentiating somatic cells using rna
07/07/2011US20110165132 Heparan Sulphate Which Binds BMP2
07/07/2011US20110165131 Methods for treating diseases and increasing longevity
07/07/2011US20110165130 Methods for Preparing Human Skin Substitutes from Human Pluripotent Stem Cells
07/07/2011US20110165128 Homing in mesenchymal stem cells
07/07/2011US20110165126 Enhanced Submucosal Tissue Graft Constructs
07/07/2011US20110165123 5' triphosphate oligonucleotide with blunt end and uses thereof
07/07/2011US20110165117 Immunogenic peptides and methods of use
07/07/2011US20110165116 Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation
07/07/2011US20110165081 Psma antibodies and uses thereof
07/07/2011US20110165080 Monoclonal antibodies and their use
07/07/2011US20110165079 Peptide for transmigration across blood brain barrier and delivery systems comprising the same
07/07/2011US20110165078 Specific binding members against synaptophysin
07/07/2011US20110165067 Carbohydrate functionalized catanionic surfactant vesicles for drug delivery
07/07/2011US20110165066 Interleukin-13 binding proteins
07/07/2011US20110165063 Il-1 binding proteins
07/07/2011CA2789196A1 Anti-iga1 antibody